The LYZL6 antibody is a specific immunological reagent designed to detect and study the protein lysozyme-like 6 (LYZL6), a member of the c-type lysozyme family. LYZL6 is primarily expressed in the male reproductive tract (testis and epididymis) and has been implicated in both reproductive functions (e.g., sperm-egg binding) and innate immune defense mechanisms . This antibody is widely used in research to localize LYZL6 in tissues, assess its expression levels, and explore its functional roles.
Gene and Protein Structure:
LYZL6 is encoded by the LYZL6 gene (NCBI Gene ID: 57151) and consists of 148 amino acids, with a calculated molecular weight of 17 kDa .
It shares structural homology with traditional lysozymes but lacks the conserved catalytic residues (Glu35 and Asp52) critical for enzymatic activity in classical lysozymes .
Tissue Expression:
Functional Roles:
| Antibody Type | Host | Applications | Reactivity | Dilution |
|---|---|---|---|---|
| Polyclonal (11922-1-AP) | Rabbit | WB, IHC, ELISA | Human, Mouse, Rat | WB: 1:500–1:1000 |
| Prestige Antibody (HPA025734) | Rabbit | IHC, Immunoblotting | Human | IHC: 1:20–1:50 |
| Affinity Isolated (AV53746) | Rabbit | Western Blot | Dog, Pig, Horse, Human | WB: 0.04–0.4 μg/mL |
Immunoneutralization of LYZL6 reduces sperm-egg fusion rates in vitro, highlighting its critical role in fertilization .
Localization studies reveal LYZL6 on the post-acrosomal membrane, suggesting involvement in sperm membrane remodeling .
Cancer Biomarkers: Elevated LYZL6 expression correlates with poor prognosis in pancreatic cancer (PC), potentially serving as a prognostic marker .
Therapeutic Targets: Anti-LY6E antibodies (e.g., DLYE5953A) demonstrate antitumor activity in solid cancers, suggesting analogous strategies for LYZL6 .
Lyse tissues (testis/epididymis) in RIPA buffer.
Separate proteins via SDS-PAGE (15% gel).
Transfer to PVDF membrane and block with 5% skim milk.
Incubate with LYZL6 antibody (1:500–1:1000) overnight at 4°C.
LYZL6 (Lysozyme-like protein 6) is a member of the C-type lysozyme/alpha-lactalbumin family with bacteriolytic properties. It plays dual roles in male reproductive biology: contributing to mitochondrial function in spermatozoa and providing innate immunity in the male genital tract . The protein is encoded by the LYZL6 gene (ID: 57151) and has a calculated molecular weight of approximately 17 kDa, which matches its observed size in experimental settings . LYZL6 is primarily expressed in the testis and epididymis in a developmentally regulated manner and appears to be controlled by androgen or testicular factors .
LYZL6 antibodies have been validated for multiple research applications, with specific validation depending on the commercial source:
| Application | Validated Antibodies | Recommended Dilutions |
|---|---|---|
| Western Blot (WB) | 11922-1-AP, A29172, CAB1067, NBP1-58032 | 1:500-1:5000 |
| Immunohistochemistry (IHC) | 11922-1-AP, A29172 | 1:20-1:200 |
| Immunofluorescence (IF) | A29172, A39713 | Varies by product |
| ELISA | 11922-1-AP, CAB1067, A13023 | 1 μg/ml (approximate) |
When selecting a LYZL6 antibody, researchers should consider the specific application requirements and test species, as reactivity profiles vary among available antibodies .
Positive detection of LYZL6 has been consistently documented in both mouse and human testis tissues using Western blot analysis . Immunohistochemistry has successfully detected LYZL6 in rat and mouse testis tissues . At the cellular level, immunodetection has revealed LYZL6 protein in primary spermatocytes and round spermatids within the testis, as well as on the post-acrosomal area and midpiece of mature epididymal spermatozoa . These localization patterns provide important insights into LYZL6's potential functions in sperm development and maturation.
For immunohistochemical detection of LYZL6 in testicular tissue, the following conditions have been recommended:
Tissue preparation: Proper fixation and sectioning of testis tissue samples
Antigen retrieval: Use of TE buffer at pH 9.0 as the preferred method, with citrate buffer at pH 6.0 as an alternative
Antibody concentration: Dilution ratios between 1:20 and 1:200 for the 11922-1-AP antibody
Controls: Include positive controls (known LYZL6-expressing testis tissue) and negative controls (antibody omission or non-expressing tissue)
The specific localization of LYZL6 to spermatocytes, round spermatids, and regions of mature sperm requires careful attention to methodological details to prevent false negatives or background staining .
Storage conditions vary slightly by manufacturer but generally follow these guidelines:
Temperature: Store at -20°C for long-term preservation of antibody activity
Buffer composition: Most LYZL6 antibodies are supplied in PBS with stabilizers such as glycerol (50%) and preservatives like sodium azide (0.02%)
Aliquoting: For antibodies without stabilizers (such as BSA-free formulations), aliquoting is recommended to minimize freeze-thaw cycles
Shelf life: When properly stored, antibodies typically maintain stability for approximately one year from the date of receipt
Some manufacturers specifically note that 20μl sizes containing 0.1% BSA do not require aliquoting for -20°C storage , while others emphasize avoiding repeated freeze-thaw cycles to preserve antibody functionality .
Comprehensive validation of LYZL6 antibodies requires several controls:
Positive tissue controls: Include known LYZL6-expressing tissues such as mouse or human testis
Recombinant protein controls: Use purified recombinant LYZL6 protein as a positive control in Western blot applications
Peptide competition assays: Pre-incubate the antibody with the immunizing peptide to demonstrate specificity through signal abolishment
Molecular weight verification: Confirm detection of a band at approximately 17 kDa, the expected molecular weight of LYZL6
Cross-reactivity assessment: Test the antibody against related lysozyme family members to ensure specificity to LYZL6
When publishing LYZL6 research, thorough documentation of validation steps enhances reproducibility and confidence in experimental findings.
LYZL6 antibodies enable several advanced research applications for investigating male fertility:
Sperm function analysis: Using immunolocalization to correlate LYZL6 expression patterns with functional parameters such as motility, capacitation, and acrosome reaction
Comparative studies: Analyzing LYZL6 expression and localization in fertility-compromised versus normal samples to identify potential biomarkers
Developmental regulation: Tracking LYZL6 expression throughout spermatogenesis and epididymal maturation to understand its temporal regulation
Molecular interactions: Employing co-immunoprecipitation with LYZL6 antibodies to identify protein binding partners in sperm
Mitochondrial function assessment: Investigating the relationship between LYZL6 expression and mitochondrial activity in sperm, given LYZL6's potential role in sperm mitochondrial function
These applications leverage LYZL6 antibodies as tools for understanding the molecular mechanisms underlying male fertility and potentially identifying targets for diagnostic or therapeutic interventions .
To investigate LYZL6's contribution to innate immunity in the male reproductive tract, researchers can employ several experimental approaches:
Bacteriolytic assays: Measuring the ability of recombinant LYZL6 to lyse bacterial cell walls using turbidimetric assays
Colony-forming unit (CFU) assays: Quantifying bacterial survival after exposure to purified LYZL6 protein
Zone inhibition assays: Evaluating antimicrobial activity against various bacterial strains through agar diffusion methods
Minimum inhibitory concentration (MIC) determination: Establishing the lowest concentration of LYZL6 that inhibits bacterial growth
In vivo models: Utilizing LYZL6-deficient animal models to assess susceptibility to reproductive tract infections
These methodologies help characterize the specificity, potency, and physiological relevance of LYZL6's antibacterial properties, particularly in the context of reproductive tract immunity .
Researchers working with LYZL6 antibodies may encounter several technical challenges:
Weak signal detection:
Non-specific binding:
Variable results across samples:
Subcellular localization discrepancies:
Solution: Compare results using antibodies targeting different epitopes
Validate with multiple detection methods (IF, IHC, subcellular fractionation)
Consider fixation method impact on epitope accessibility
Several commercial LYZL6 antibodies are available with varying characteristics that may influence performance:
Performance differences may relate to:
Epitope recognition: Antibodies targeting different regions may yield varying results in applications where protein conformation or interactions affect epitope accessibility
Cross-reactivity: Broader species reactivity may indicate conserved epitopes but potentially increases non-specific binding
Purification method: Affinity-purified antibodies typically offer higher specificity than crude antisera
Researchers should select antibodies based on their specific experimental requirements and validate performance in their particular system .
Different sample types require specific methodological adaptations for optimal LYZL6 detection:
Testicular tissue sections:
Epididymal tissue:
May require milder antigen retrieval conditions
Optimize blocking to reduce background in this highly secretory tissue
Isolated sperm cells:
Mild fixation to preserve membrane integrity
Permeabilization optimization for access to subcellular compartments
Appropriate blocking to reduce non-specific binding to sperm surfaces
Cell lines (for recombinant expression):
Lysis buffer optimization based on subcellular localization
Consider native versus denaturing conditions for Western blot
Human clinical samples:
Standardized collection and processing protocols
Careful validation using positive and negative controls
Consideration of patient variability factors
Each sample type presents unique challenges for LYZL6 detection, requiring systematic optimization of protocols for reliable and reproducible results.
LYZL6 research shows potential for advancing male infertility diagnostics in several ways:
Biomarker development: LYZL6's dual role in sperm function and antimicrobial activity positions it as a potential biomarker for specific types of male infertility
Functional assays: Detection of abnormal LYZL6 expression or localization patterns could identify previously uncharacterized causes of infertility
Genetic screening: Identification of LYZL6 gene variants associated with infertility could enable targeted genetic testing
Immunological assessment: Evaluation of anti-LYZL6 autoantibodies might reveal immunological causes of infertility
Sperm function prediction: Correlation between LYZL6 expression/activity and fertilization capacity could improve predictive capabilities for assisted reproductive technologies
Understanding LYZL6's role in fertility may lead to innovative diagnostic approaches that provide more specific information about the underlying causes of male infertility, potentially enabling more personalized treatment strategies .
The LYZL (lysozyme-like) family includes several members with roles in reproductive biology:
LYZL1: Expressed in testis and epididymis in a developmentally regulated manner, though its specific function remains unclear
LYZL4: Reported to play a role in sperm-egg binding and fertilization in mice
LYZL6: Associated with mitochondrial function in spermatozoa and contributes to innate immunity in the male reproductive tract
SPACA3 (LYZL3): Involved in sperm-egg binding and fertilization processes
These family members share structural similarity to lysozyme but appear to have evolved specialized functions in reproduction. While some members (LYZL4, SPACA3) have more established roles in fertilization events, LYZL6 seems uniquely positioned at the intersection of sperm function and antimicrobial defense . This functional diversification within a conserved protein family represents an interesting example of evolutionary adaptation in reproductive biology.
Research into LYZL6's role in sperm mitochondrial function is an emerging area that employs several advanced techniques:
High-resolution microscopy:
Super-resolution imaging to precisely localize LYZL6 relative to mitochondrial structures
Correlative light and electron microscopy to connect protein localization with ultrastructural features
Functional mitochondrial assays:
Measurement of mitochondrial membrane potential in LYZL6-manipulated sperm
Assessment of ATP production capacity and metabolic profiles
Evaluation of reactive oxygen species generation
Molecular interaction studies:
Proximity ligation assays to identify LYZL6 interactions with mitochondrial proteins
Co-immunoprecipitation combined with mass spectrometry to identify binding partners
Genetic approaches:
CRISPR-Cas9 mediated knockout or knockin models to assess functional consequences
Site-directed mutagenesis to identify critical domains for mitochondrial function
These techniques help elucidate the molecular mechanisms by which LYZL6 influences mitochondrial function in spermatozoa, potentially revealing new targets for treating specific forms of male infertility related to sperm energetics .